LTRN Lantern Pharma

Watchlist

4.130
-0.200-4.62%

Close Feb 24 16:00 ET

4.330
+0.200+4.84%

Post 18:04 ET

44.54MMarket Cap-2.32P/E (TTM)

About Lantern Pharma Company

Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.

Company Profile

SymbolLTRN

Company NameLantern Pharma

Listing DateJun 11, 2020

Issue Price15.00

Founded2013

CEOMr. Panna L. Sharma

MarketNASDAQ

Employees21

Fiscal Year Ends12-31

Address1920 McKinney Avenue,7th floor

CityDallas

ProvinceTexas

CountryUnited States of America

Zip Code75201

Phone1-972-277-1136

Websitehttp://www.lanternpharma.com

Company Executives

Name
Position
Salary

Panna L. Sharma
Chief Executive Officer, President and Director
684.39K

David R. Margrave
Principal Accounting Officer, Chief Financial Officer and Secretary
442.68K

Dr. Kishor G. Bhatia, PhD
Chief Scientific Officer
283.24K

Donald Jeffrey Keyser
Chairman of the Board
56.00K

David S. Silberstein
Director
46.00K

Dr. Vijay Chandru
Independent Director
46.00K

Dr. Maria Maccecchini, PhD
Independent Director
51.00K

LTRN Lantern Pharma

About Lantern Pharma Company

Company Profile

Company Executives

Trending Stocks